These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6765432)

  • 1. [The saralasin bolus test in the diagnosis of arterial hypertension].
    Mazza F; Messore T; Genovese A; De Alfieri W; Corvino A; Catalano M; Condorelli M
    Cardiologia; 1982; 27(3):289-92. PubMed ID: 6765432
    [No Abstract]   [Full Text] [Related]  

  • 2. [Significance of the saralasin infusion test in the diagnosis of arterial hypertension].
    Glorioso N; Madeddu P; Dessì-Fulgheri P; Meloni F; Palermo M; Fiori C; Rappelli A
    Boll Soc Ital Cardiol; 1980; 25(9):1035-46. PubMed ID: 7025868
    [No Abstract]   [Full Text] [Related]  

  • 3. [Role of a competitive antagonist of angiotensin II (saralasin) in the diagnosis and therapy of arterial hypertension].
    Mazza F; Messore T; Catzola A; Corvino A; Genovese A; Catalano M; Mercone G
    Recenti Prog Med; 1983 Apr; 74(4):415-29. PubMed ID: 6348901
    [No Abstract]   [Full Text] [Related]  

  • 4. [The saralasin test in clinical evaluation of hypertensive states].
    Cremoncini C; Cremoncini M; Libroia A; Vignati E; Botalla L
    Boll Soc Ital Cardiol; 1978; 23(8):1291-7. PubMed ID: 398708
    [No Abstract]   [Full Text] [Related]  

  • 5. [The Saralasin test in the diagnosis of renovascular hypertension. Personal experience].
    Giuliani L; Martorana G; Giberti C
    Minerva Nefrol; 1979; 26(4):623-8. PubMed ID: 396491
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of saralasin on the activity of the renin-angiotensin-aldosterone system, sympathetic-adrenal system and the level of the 6-keto-PGF1 alpha metabolite of prostacyclin in patients with primary arterial hypertension].
    Bar-Andziak E; Ignatowska-Switalska H; Wocial B; Kabat M; Makowiecka-Cieśla M; Cybulska I; Sznajderman M
    Kardiol Pol; 1985; 28(7):481-8. PubMed ID: 3910904
    [No Abstract]   [Full Text] [Related]  

  • 7. [Saralasin bolus test in the diagnosis of arterial hypertension].
    Mazza F; Messore T; Genovese A; De Alfieri W; Corvino A; Catalano M; Condorelli M
    Cardiologia; 1982; 27(3):289-92. PubMed ID: 6892458
    [No Abstract]   [Full Text] [Related]  

  • 8. [Saralasin in the diagnosis of angiotensin-dependent hypertension and in the study of the renin-angiotensin-aldosterone system].
    Falch D
    Tidsskr Nor Laegeforen; 1983 Apr; 103(11):906-8. PubMed ID: 6879526
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diagnostic relevancy of saralasin in renin-dependent hypertension].
    Röckel A; Wernze H; Spech HJ; Scheitza E; Hennemann H; Heidland A
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1307-10. PubMed ID: 1029985
    [No Abstract]   [Full Text] [Related]  

  • 10. [Differential diagnosis of hypertension using the angiotensin II antagonist saralasin].
    Knauf H; Burmeister P; Büttner C; Hoppe-Seyler G; Schollmeyer P
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():214-5. PubMed ID: 613578
    [No Abstract]   [Full Text] [Related]  

  • 11. [Saralasin in subjects with low renin arterial hypertension].
    Frisina N; Buemi M; Lasco A; Macrí I; Ciraolo O; Nicita Mauro V; Costa G
    Boll Soc Ital Biol Sper; 1980 Jul; 56(13):1367-73. PubMed ID: 7004464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of saralasin as a diagnostic test in hypertension. Report of a Consensus Committee.
    Arch Intern Med; 1982 Aug; 142(8):1437-40. PubMed ID: 7049102
    [No Abstract]   [Full Text] [Related]  

  • 13. Saralasin infusion in renovascular and essential hypertension.
    Thien T; Hoefnagels WH
    Neth J Med; 1980; 23(2):68-73. PubMed ID: 6990282
    [No Abstract]   [Full Text] [Related]  

  • 14. [Saralasin test in the differential diagnosis of essential and renal hypertension].
    Scholze J; Matzke J; Homuth V; Frille J; Scholz D; Faulhaber HD; Engelhardt I; Hartrodt W; Naumann E; Buder HW
    Z Urol Nephrol; 1986 Feb; 79(2):101-16. PubMed ID: 3518278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertensive mechanisms in coarctation of the aorta. Further studies of the renin-angiotensin system.
    Parker FB; Farrell B; Streeten DH; Blackman MS; Sondheimer HM; Anderson GH
    J Thorac Cardiovasc Surg; 1980 Oct; 80(4):568-73. PubMed ID: 6999245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension screening and treatment with angiotensin inhibitors. Saralasin and captopril.
    Zawada ET; Stinson J; Ramirez G
    Postgrad Med; 1980 Oct; 68(4):89-92, 94-5, 98. PubMed ID: 6999479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application of the saralasin test to the treatment of malignant or accelerated arterial hypertension (author's transl)].
    Bonnet F; Corvol P; Thibonnier M; Reach G; Lardoux MD; Milliez P
    Nouv Presse Med; 1980 Nov; 9(41):3075-8. PubMed ID: 7443447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The relationship between lymphocyte sodium content and the renin-angiotensin-aldosterone system in subjects with essential arterial hypertension].
    Violi F; Santucci A; Aguglia F; De Mattia G
    Clin Ter; 1981 Nov; 99(3):277-80. PubMed ID: 7030588
    [No Abstract]   [Full Text] [Related]  

  • 19. [Vasopressin and renin-aldosterone system in patients with arterial hypertension].
    Kasenova SL
    Klin Med (Mosk); 2002; 80(12):31-4. PubMed ID: 12638408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interrelationship between the brain and kidney renin--angiotensin systems in combined hypertension: the effect of a central block with saralasin].
    Lakova E; Stoĭnev A
    Eksp Med Morfol; 1981; 20(3):134-9. PubMed ID: 7308121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.